Circular RNA circMTO1 has been reported to inhibit the progression of many types of cancers. However, the role of circMTO1 in the progression of glioblastoma remains unclear. The purpose of our study was to explore the potential involvement of circMTO1 in glioblastoma.
Background
In the central nervous system, glioblastoma is the most common tumor with highly malignancy [1] . Despite significant improvements in standard treatment for glioblastoma, the overall survival of patients with glioblastoma is only 15-18 months [2, 3] . Thus, it is imperative to explore the genetic regulatory networks associated with the progression and development of glioblastoma.
Circular RNAs (circRNAs), a new member of the endogenous non-coding RNAs family, have been reported to play important roles in the occurrence and progression of many types of cancers [4] [5] [6] [7] , such as breast cancer [8] , colorectal cancer [9] , ovarian cancer [10] , gastric cancer [11] , hepatocellular carcinoma [12] , and glioblastoma [13] . Accumulating evidence indicates that circRNAs serve as a tumor suppressor or oncogenic gene and are involved in regulating cancer cell differentiation, proliferation, metastases, and chemosensitivity [14, 15] . CircMTO1 (mitochondrial translation optimization 1 homologue) has been demonstrated to act as a tumor suppressor in many human cancers [16] [17] [18] [19] . Recently, it has been reported that circMTO1 is significantly downregulated in human hepatocellular carcinoma tissues, and inhibits the progression of hepatocellular carcinoma by acting as the sponge of oncogenic miR-9 to promote p21 expression [16] . In addition, circ-MTO1 suppresses the proliferation and invasion of colorectal cancer cells through regulating the Wnt/b-catenin signaling pathway [19] . However, the functional roles of circMTO1 in the pathogenesis of glioblastoma and the molecular mechanisms underlying these roles remain unclear.
In the present study, we first investigated the expression of circMTO1 in human glioblastoma tissues, and the effects of circMTO1 on proliferation of human glioblastoma cells were examined. Furthermore, we also explored the molecular mechanisms underlying these effects. 
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Material and Methods
Clinical samples
Our study was approved by the Research Ethic Committee of Yidu Central Hospital of Weifang (2015-50). Glioblastoma tissues and corresponding normal tissues derived from 59 patients with glioblastoma were collected from the Department of Neurosurgery, Yidu Central Hospital of Weifang, between January 2015 and January 2018. Written informed consent was obtained from all patients.
Cell culture
Normal human astrocytes (NHA) cells and human glioblastoma cancer cell lines (A172, U251, U87, SNB19, and SHG44) were purchased from ATCC (American Type Culture Collection). These cell lines were cultured in DMEM (Dulbecco's modified Eagle's medium) (HyClone, USA) at 37°C with 5% CO 2 . This medium was supplemented with 10% FBS (fetal bovine serum) (Gibco, USA).
Quantitative real-time PCR
The total RNA was extracted by using TRIzol purchased from Invitrogen (Thermo Fisher Scientific, Inc.). According to the manufacturer's instructions, the extraction of RNA was performed. Primers for circMTO1, miR-92, and WWOX were obtained from Invitrogen Bioengineering Corporation (Shanghai, China). qRT-PCR was carried out as previously described [20] . The relative mRNA expression levels of genes were calculated via using the 2 -DDCt method.
Western blot analysis
The protein expression of WWOX was measured via Western blot analysis, performed as previously described [21] . Antibodies against WWOX (ab189410) and GAPDH (ab181602) were obtained from Abcam (Cambridge, UK). Electrochemiluminescence material was obtained from Millipore.
Cell proliferation assay
The effect of circMTO1, miR-92, and WWOX on glioblastoma cell proliferation were assessed via CCK-8 assay and colony formation assay. Cell Counting Kit-8 was obtained from Dojindo. CCK-8 and colony formation assays were carried out as previously described [22] . 
Dual-luciferase reporter assay
The regulatory interaction between circMTO1 and miR-92 was investigated via dual-luciferase reporter assay. The vectors of circMTO1-WT (wild-type), circMTO1-MT (mutant-type), WWOX-WT, and WWOX-MT were constructed. Then, these vectors were transfected into U251 cells with miR-92-mimics or NC-mimics. Luciferase reporter assays were performed as previously described [23] .
Statistical analysis
All data are presented as mean ± standard deviation (SD). The overall survival of patients with glioblastoma was assessed with Kaplan-Meier method. The difference between the 2 groups was determined via the t test. P<0.05 was considered statistically significant.
Results
The expression of circMTO1 is decreased and is associated with poor prognosis of glioblastoma patients
To assess the expression of circMTO1 in glioblastoma, we detected its expression in 59 paired glioblastoma tissues and corresponding adjacent normal tissues via qRT-PCR. As shown in Figure 1A , compared with normal tissues, the expression of circMTO1 was decreased in glioblastoma tissues. In addition, the overall survival of patients with lower expression of circ-MTO1 was decreased ( Figure 1B) . Meanwhile, the expression of circMTO1 was downregulated in human glioblastoma cancer cell lines (A172, U251, U87, SNB19, and SHG44) relative to normal human astrocytes (NHA) ( Figure 1C ). These findings indicate that the low expression of circMTO1 is associated with poor prognosis of glioblastoma patients.
CircMTO1 inhibits glioblastoma cells proliferation
To investigate the effect of circMTO1 in glioblastoma cell proliferation, the CCK-8 assay and colony formation assay were 
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performed in U251 cells transfected with si-circMTO1 or si-NC. QRT-PCR indicated that the expression of circMTO1 in U251 cells transfected with si-circMTO1 was obviously reduced compared with the si-NC group (Figure 2A) . The results of CCK-8 assay showed that silencing of circMTO1 significantly promoted U251 cell proliferation ( Figure 2B ), and a similar result was provided by colony formation assay ( Figure 2C ). These data show that circMTO1 suppresses glioblastoma cell proliferation.
WWOX is involved in glioblastoma cells proliferation inhibited by circMTO1
WWOX, a tumor suppressor gene, inhibits the proliferation of various cancer cells [24] [25] [26] , including glioblastoma cells [27] .
To investigate the effect of circMTO1 on the expression of WWOX, its expression in U251 cells transfected with si-circ-MTO1 or si-NC was determined by qRT-PCR and Western blot. The results showed that silencing of circMTO1 significantly downregulated the mRNA and protein expression of WWOX ( Figure 3A, 3B) . To further explore the role of WWOX in glioblastoma cell proliferation inhibited by circMTO1, the CCK-8 assay and colony formation assay were performed in U251 cells transfected with si-WWOX or si-WWOX-control. We found that silenced WWOX blocked the inhibitory effect of circMTO1 on proliferation of U251 cells ( Figure 3C, 3D ). These observations indicate that WWOX is involved in glioblastoma cell proliferation inhibited by circMTO1.
CircMTO1 sponges miR-92 in glioblastoma cells
CircRNAs play important roles in the development and progression of cancer by acting as a competing endogenous RNA (ceRNA) to interact with miRNAs [28] . To further explore the molecular mechanisms of circMTO1-induced WWOX expression, the potential circRNA-miRNA interactions were predicted via StarBase prediction software. As shown in Figure 4A , miR-92 was found to have a potential binding site with circMTO1. The dual-luciferase reporter assays verified these findings ( Figure 4B ). Moreover, ablation of circMTO1 led to a significant increase in miR-92 expression in U251 cells ( Figure 4C ). Correlation analysis showed a negative relationship between circMTO1 and miR-92 in glioblastoma tissues ( Figure 4D ). These results suggest that circMTO1 sponges miR-92 in glioblastoma cells. 
WWOX is a target of miR-92
To further investigate the role of miR-92 in the expression of WWOX induced by circMTO1, the potential miR-92 binding sites in the 3'-UTR of WWOX were predicted through StarBase prediction software. The results indicated that miR-92 can bind to WWOX mRNA ( Figure 5A ) and a binding interaction between them was shown by luciferase reporter assays ( Figure 5B ). Additionally, miR-92 remarkably downregulated the expression of WWOX in U251 cells ( Figure 5C ), which is consistent with the inverse correlation of miR-92 and WWOX in glioblastoma tissues ( Figure 5D ). In conclusion, these data demonstrate that WWOX is a target of miR-92 in glioblastoma cells.
Discussion
Accumulating evidence demonstrates that circRNAs play important roles in the occurrence and progression of many types of cancers [4] [5] [6] [7] . Glioblastoma is the most common primary cancer derived from the central nervous system [29] . However, little is known about the functional roles of circMTO1 in the pathogenesis of glioblastoma and the molecular mechanisms underlying these roles. In this study, we found that circMTO1 was markedly downregulated in glioblastoma tissues. The lower expression of circMTO1 was significantly associated with shorter overall survival of patients with glioblastoma. Moreover, circ-MTO1 suppressed glioblastoma cell proliferation by regulating the expression of WWOX. More importantly, circMTO1 can directly interact with miR-92, and subsequently serve as a miRNA sponge to upregulate WWOX expression.
CircMTO1 been shown to act as tumor suppressor in many human cancers [16] [17] [18] [19] . Recently, it has been reported that circ-MTO1 is significantly downregulated in human hepatocellular carcinoma tissues and inhibits the progression of hepatocellular carcinoma [16] . Additionally, circMTO1 can suppresses the proliferation and invasion of colorectal cancer cells through regulating the Wnt/b-catenin signaling pathway [19] . However, the functional roles of circMTO1 in the pathogenesis of glioblastoma remain unknown. Similar to previous findings, we showed that circMTO1 also served as a tumor suppressor in glioblastoma. Our results indicate that the lower expression of circMTO1 was significantly associated with shorter overall survival of patients with glioblastoma. In addition, circMTO1 suppressed glioblastoma cell proliferation. However, a recent 6459 study confirmed that circMTO1 can also act as a cancer-promoting gene and accelerate tumorigenesis and chemoresistance of cervical cancer through regulating miR-6893 [30] .
The mechanisms for the functional roles circRNAs in the occurrence and development of cancer are not completely clear. However, emerging evidence confirms that circRNAs can regulate the expression of tumor-suppressive or oncogenic genes through serving as miRNA sponges and forming the circRNAmiRNA-mRNA axis [31] [32] [33] [34] . It has been reported that circMTO1 inhibits the growth of hepatocellular carcinoma by acting as the sponge of oncogenic miR-9 to promote p21 expression [16] . Furthermore, circMTO1 inhibits bladder cancer metastasis by suppressing epithelial-to-mesenchymal transition through sponging miR-221 [18] . WWOX, a tumor-suppressor gene, has inhibitory effects on proliferation of various cancer cells [24] [25] [26] , including glioblastoma cells [27] . In the present study, we demonstrated that circMTO1 directly interacts with miR-92 and subsequently serve as a miRNA sponge to upregulate WWOX expression.
Conclusions
We identified for the first time that circMTO1 is significantly downregulated in glioblastoma tissues and is associated with poor prognosis of patients. In addition, we also demonstrate that circMTO1 can inhibit the proliferation of glioblastoma cells by serving as a miR-92 sponge to induce WWOX expression. The present data verified that the circMTO1-miR-92-WWOX axis may be a therapeutic target for the management of glioblastoma.
